Some sporadic insights into academia.
Science is Fascinating.
Scientists are slightly peculiar.
Here are the views of one of them.
Buy My Book

Monday, 24 October 2016

Time for T? The role of T cells in influenza vaccination.

It is approaching flu season again. If you are in any way susceptible to flu – over 65, have an underlying health condition (asthma, MS, pregnancy) get the flu vaccine (I have nagged my parents already – but Mum, Dad if you are reading this don’t forget). The current flu vaccine works well and will protect you against this year’s flu.

See my coat of many, many colours

But we could do better. Vaccines work by training your body to recognise the coat that surrounds the flu virus. The big problem is that flu mutates, changing its coat, hiding from our immune system. The gene machinery encoded by the influenza virus is inefficient (leaky). Imagine using a photocopier to make repeat copies of the same document each time using the copy as the template for the next round; over time the quality of the copies declines. DNA is copied in the same way with faults in the copies leading to errors in genes (mutations), most of which are harmless, some harmful and some beneficial – this is the driving engine of evolution. Eukaryotic cells (us) have proofreading in the gene copying machinery, if a faulty copy is made it is deleted, viruses do not have this, so the chance of a faulty copy increases. This means that viruses can mutate/ change quickly leading to the emergence of new viruses with new coats each year necessitating new vaccines.

Killer cells

A goal of influenza research is to develop vaccines that cover a wider spectrum of viruses – the universal flu vaccine. But to achieve this goal, we need to understand more about the way in which the body fights off flu infection. This is what we set out to do in our recently published paper: “DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8+ T Cell Responses, Enabling Faster Resolution of Influenza Disease”. Using unique vaccines from our Norwegian collaborators, Vaccibody, we dissected one aspect of the immune response called the CD8 T cell. These cells are able to sense when other cells have viruses in them and then kill the infected cells. The vaccines are designed to target different types of cells and can be used to alter the flavour of the immune response. Using a CD8 T cells specific Vaccibody, we showed was that vaccines that evoke a T cell response led to a faster resolution of disease – infected animals got better, quicker. This is important because the influenza virus may be less good at escaping CD8 T cells than other parts of the immune response. Based on these studies, we believe that the next generation of influenza vaccines need to increase the CD8 T cell response. This idea is supported by research performed during the influenza pandemic in 2009: patients who had a functional CD8 response were much less likely to get sick after infection. The more we understand about the immune response, the better vaccines get and the less people will  get sick from infections.

Thursday, 8 September 2016

Startup Advice

What was the most helpful advice I got when starting my group? There is no answer to that question because, like most of my colleagues, I didn’t get any. I got the keys to the lab, a nice pub lunch, a PC, a small amount of start-up money and a seat in a shared office in which the most commonly used word was “fuck”.But while there is no disgrace in lying for comic effect, I should confess that, in reality, I did get two pieces of advice. One was a not-so-helpful recommendation to never become a PI in the first place because it was hard and getting harder. The other, much more helpful recommendation was to read Kathy Barker’s book At the Helm: Leading Your Laboratory. It is thorough and thought-provoking, and covers the whole spectrum of the academic experience from situations you will have considered to those that you will never have imagined (and hopefully will never be in).
In the absence of any further second-hand advice to pass on, here are the key things I had to learn the hard way:
Learn to say no
New staff represent a brilliant opportunity to offload unpopular lectures, roles on health and safety committees and other rubbish no one else wants to do. Do not unwittingly take on busywork in an attempt to be popular with the cool kids; otherwise you too will end up having to dump it on the next generation.
If you do say yes, do it well
Being a safe pair of hands is a valuable skill. If you can be trusted to deliver something tricky, you will raise your profile in the department. But be aware: competence can lead to an even heavier workload.
Get some top cover
From providing lab space and access to equipment, to mentoring and speaking up for you on promotion committees, you need someone senior to look out for you; find someone simpatico.
Build a brand
A dirty word in academic circles, but important. It’s a big and competitive world, and being known as the expert in a particular area or technique will lead to collaborations and conference invitations.
Recruit the right team (for you)
I am lucky enough to have a fantastic team. But picking the wrong people will lead to a toxic lab culture that will sink you. The first person you recruit sets the tone for the rest of your career. Get experience of interviewing by being on recruitment panels for colleagues. Think very carefully about the process, particularly the questions you ask and what characteristic they actually probe. Then choose your recruit very carefully.
Toughen the heck up
You are going to fail, often. Even well-established PIs fail. It is part of the process. Learn methods to deal with it.
Be a tiger
Remember that you earned this position on your ability; try not to let impostor syndrome overcome you.
Have fun
Academia is tough, but there are good bits: don’t forget to enjoy them.


This first appeared in the Times Higher Education on 8th September 2016

Thursday, 1 September 2016

Cheer up its only brexit


On the slow return from the long vacation, as a community, we academics find ourselves in a bit of a post-referendum pickle (I think it is a reasonable assumption that most academics were anti-Brexit).
Put aside the shock that “not everyone thinks like us”. Regardless of the final outcome of Brexiting, we are in for a time of uncertainty. We can face this uncertainty in two ways: hand-wringing pessimism or fatalistic optimism. In private, I find myself swinging between these viewpoints; but in public, I take on the role of departmental pessimism-eater: for every “woe is us” I respond with “it’ll be OK”; for every cloud a silver lining and for every hand-wring a cheery backslap.
I admit this Pollyanna approach can be quite annoying.

Reasons not to be miserable
The silver linings feel few and far between. However, I take hope from the following:
  • Thirteen non-European Union nations, through one mechanism or another, can access Horizon 2020 funding, suggesting that it will be possible for the UK, too
  • At present, due to government imposed restrictions, we are basically limited to recruiting from within the EU. In the future, employing non-EU nationals may become easier, broadening the talent pool
  • The arguments for and against the EU were tight, and while to us Remain felt like the least bad option, not everyone voting Leave was a frothing-at-the-mouth Little Englander
  • The pound diving means that grants won in foreign currencies are now worth more, and a possible reduction in house prices and interest rates may allow “generation rent” to get on the property ladder (provided that they haven’t spent their deposit money on Poké Balls).
Ultimately, in the months since the referendum, unless you are a politician, nothing has actually changed: Blackshirts have not been marching in Whitechapel, countries in the EU still need to sell us cheese, wine and fast cars, and as far as I can tell the stock market is at exactly the same place as it was a year ago.

Things can only get worse
Of course all of the above may be bollocks, and Brexit should be seen as another contributory factor to the inevitable decline of British universities. For example, economic uncertainty may affect medium to long-term investment, some British-based scientists have been dropped from Horizon 2020 projects, the economy has slowed down prompting the record low interest rates, and the rhetoric from some EU politicians has been fairly acerbic, prompting fears that the exit process will not be pain-free.
You no doubt have your own personal favourite reason that we are all DOOMED, but I believe that optimism can break the debilitating miasma of gloom (perpetuated by social media) that is hanging over the ivory tower.
Critically, our happiness is – mostly – under our control, we can become more happy by doing more of the things that make us happy (reading, exercising, enjoying our jobs, pausing to notice the little things). Moping around, blaming the government/anyone who voted Leave/Donald Trump for all that ails you is, a bit like fast food, satisfying in the short term, but leaves you bloated and sad.
But don’t just take my word for it; TED talks are littered with talks about the value of positive psychology.

The wind in academia doesn’t blow, it sucks
This optimistic mindset extends beyond the current crise du jour and is a core skill for a better, happier, more productive career.
Academia is characterised by a string of events over which we have little control: student expectations, student realities, grant panels, peer reviews, promotions boards, Tory governments, global recessions, equipment not working, experiments not working, students not working, the lack of a tea room on campus and exponential increases in teaching load because in a moment of weakness you said yes to a pleading colleague.
You can throw your hands in the air, say “this is all shit” and run the clock down to retirement on your ever-decreasing pension pot.
Or you can brush yourself off and start again.

Best foot forward
Do not let each negative comment eat away at you and become embittered. Although tempting, especially when reviewing too soon after your own work has been rejected, poisoning the well for others with angry reviews, adding to a vicious cycle of rejection and recrimination, ends up making life terrible for everyone.
If you are not concerned with the general mental well-being of the body académique, there is a more selfish reason to be optimistic: pessimism directly affects your ability to succeed. Simplistically, you will never get funded if you don’t apply for grants because “no one ever gets funded”.
But additionally, if you don’t believe in a grant or paper, then why would the reviewer? So, cheer up. It’s a new academic year after all, and we have just had eight blessed weeks with no students to fix all the things that they have broken, catch up on all the paperwork they have generated, and maybe squeeze in some uninterrupted thought before the next intake.

Finally, don’t mourn, organise
I want to clarify something here.
I am not endorsing accepting the current state of affairs and doing nothing. Get out there and do something, anything: join a political party, write to your MP, contact the Commons Science and Technology Committee, demand that your professional body canvases Parliament, take to the streets and engage with others.
I am, however, endorsing a mindset to deal with the state that we are in. Look for the positives in the situation and do not let things that are out of your control affect your ability to manage the things that are in your control. To paraphrase Reinhold Niebuhr: “Have the strength to accept the things you cannot change, the courage to change the things you can, and the wisdom to tell the difference”.

This article first appeared in the Times Higher Education on 1st September 2016

Wednesday, 29 June 2016

Too much data

A Simple Screening Approach To Prioritize Genes for Functional Analysis Identifies a Role for Interferon Regulatory Factor 7 in the Control of Respiratory Syncytial Virus Disease

Scientists love data. It is like flower to florists, canvas to artists, money to bankers or ingredients to chefs. It answers the questions we have and sets the direction for new ones. From Mendel and his pea plants to Darwin and his finches through Rosalind Franklin and her X-ray crystals of DNA to CERN and their atom smashing tube thingy, the aim of experiments is to generate data to answer questions. We invest considerable time and effort to work out if the data we have is true and representative of the whole or a unique subset caused by chance (statistics) or the way we did the study (experimental design). We often repeat the same experiment multiple times to convince ourselves (and more importantly others) about the validity of our data. Without data, we are just messing around in a white coat.

Too much data

So you would think the more data the better. However, you can have too much of a good thing. Whereas before you would ask does my treatment increase or decrease a single factor, we can now measure 1000’s of things in a single experiment generating huge piles of data (datasets).In biology,, methods that generate large datasets are described as ‘omics. This is named after the genome (all the genes that make up an organism). We now have the transcriptome (all the mRNA – the messages that make proteins - at a certain timepoint), the proteome (all the proteins), the metabolome (all of the bacteria), the microbiome (all of the bacteria on or in the body) and the gnomeome (the number of garden ornaments per square metre). Each technique generates a long list of stuff that goes up or down after a certain treatment. These long lists of data are where the problems arise, being comprised of genes with weird short names like IFIT1, LILRB4, IIGP1 many of which have no known function. All of which leads to a mountain of data languishing in supplemental tables of half-read papers in obscure journals.

Biologist + computer = ???Xxx!!!

The surfeit of data has led to a whole new discipline to interpret these lists called bioinformatics. But bioinformatics requires special skills, knowledge of the mythical ‘R’ programming language, access to software tools with laborious jokey names based on forced acronyms like PICrust (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) and time. Faced with these datasets, I get a bit flustered: like many biologists, I type with 2 fingers, get nervous flushes if someone mentions Linux and can just about use Excel to add two numbers together. This is a problem because it means that there is a wealth of data out there that is inaccessible to me.

Bioinformatics for dummies

I am interested in how the body fights off viral infections in the lungs, particularly a virus called Respiratory Syncytial Virus (RSV). Part of the body’s defences is a family of proteins that restrict viruses ability to hijack our cells to make copies of themselves. There are a lot of these proteins, many of which we have no idea about how they work. A brief look at some of the ‘omics studies reveals long lists of these proteins, with no insight as to what they do. There are probably clever, but inaccessible, AI based algorithms that can search for all the relevant papers and compile them somehow; but I wouldn’t know how to use them or even where to start looking. Instead we used a ‘brute force’ approach, which meant that I/we/Jaq (first author on the paper) sat down and searched for every paper ever published on RSV that contained a big data. Having found the papers, we then harvested the gene lists from them. This was not trivial, some of the papers had to be ignored because they had inaccessible data locked behind pay walls, or were in Chinese, or were just rubbish papers or a combination of the three. But we were left with gene lists from 33 papers and stuck all the data in a big pile. At this point we employed the services of Derek, a bonafide bioinformatician, who through some computer wizardry wrote us a piece of software called geneIDs (which is freely available here, if you need such a thing), which handily counts and ranks the genes. This gave us a brand new list of all the other lists (sometimes called metadata) which can then be used as the basis for further analysis. Which we did and published the results here.

More data: better tools

First of all we compared our computer generated list to some new data from a clinical study. Children with severe RSV had higher levels of 56% of the genes on our list. This supports the approach demonstrating that the genes are important during infection. Taking a subset of these genes, we then performed experiments that showed that they are able to reduce RSV ability to infect cells and animals. In particular we demonstrated that a gene called IRF7 was central to the anti-RSV response. So ultimately the answer to the question, can you have too much data is no, but there is a need for tools to interpret it. In the current study we developed one such tool, which we feel is more accessible to biologists with little to no computer skills.
 

Monday, 27 June 2016

Sweeter lungs more bugs

Jam jar lungs
Why do some people, for example people with diabetes, get colds more often? We believe we have found a contributing factor – sugar, in particular glucose. Diabetes is defined by elevated blood glucose. 13 years ago, Prof Emma Baker and Prof Debbie Baines (at St George’s University of London) noticed that additionally, people with diabetes have increased airway glucose. Normally, the cells that line the airways pump any glucose that leaks into the lungs back into the blood. In diabetes, there is too much sugar in the blood and the pumps are overwhelmed, leading to a rise in airway glucose.  They hypothesized that the increased level of sugar in the lungs would allow more bacteria to grow in the lungs – the biological equivalent of leaving a jam jar open!

Diabetes = more lung bacteria

In our latest paper (Increased airway glucose increases airway bacterial load in hyperglycaemia) we set out to test this hypothesis using a number of different techniques. First we looked in hospitalised patients to see if there was a link between glucose and bacterial infection, and there was, patients with high blood sugar were twice as likely to have a bacterial lung infection. We know this thanks to our collaborators, Dr Luke Moore and Professor Alison Holmes, who have been tracking bacterial infections in London hospitals. This kind of a study is called an association or correlation study, and these studies are very good at showing that one thing is linked to another, but do not tell whether the link is causal and if it is how (the mechanism in scientific parlance).

Knockout bugs


In order to understand the how, we investigated how bacteria use glucose in the lung. The way we do this is to delete individual bacterial genes and compare the function of these gene deleted mutant bacteria to bacteria with all their genes (wild type). We deleted four different genes that based on their shape and similarities to genes from other bacteria were predicted to be important for the bug to be able to use glucose. These studies were performed using a bacteria called Pseudomonas aeruginosa, which, unless you have cystic fibrosis, you’ve probably never heard of, but causes many cases of pneumonia each year, especially in hospitalised patients. The first step was to demonstrate that deleting the genes affected Pseudomonas ability to use glucose to grow. Great news, they do.

Hypothesis - tested


The final step was to link everything - high glucose, in the lungs and bacteria - together. We did this using mice with diabetes (yes they do exist). As seen in people with diabetes, diabetic mice get more severe bacterial lung infections, unless you infect them with bacteria that can’t use glucose. When these bacteria were used, there was no difference in the bacterial lung infection. Boom, job done.

Drugs for bugs

But why stop there, understanding the factors that increase infection gives us new ways to fight infection. This is particularly important for bacterial infections because our arsenal of antibiotics is rapidly being depleted and we desperately need new treatments. If increased lung glucose increases infection it follows that drugs that reduce lung glucose should reduce infection. We tested the common anti-diabetic drug, metformin. Diabetic mice treated with metformin had lower lung glucose and less bacterial infection.

In conclusion, we have linked increased bacterial infection in people with diabetes to the level of glucose in the lungs, and used this finding to test new antibacterial treatments. If you want to read more details the paper is here.

Monday, 13 June 2016

Failing to fail gracefully


Advice: easier to give than to follow

This time last year, I wrote ten strategies to improve mental health in academic life. I think they’re worth reading, if you haven’t already. You’d think that having given all this advice, I would have followed it, and maintained a Zen-like calm. Not so.


In the last year I have allowed failure (and the prospect of failure) to define my mood, compared my progress with researchers several leagues above me and found myself wanting, got too obsessed with work to appreciate anything else, taken on more than I can manage, unsuccessfully disguised my jealousy about colleagues’ success, taken criticism as a personal attack, and not spoken to anyone about what was going on in my head.
Whilst reflecting on my inability to follow my own advice, this year I wanted to come up with something that I could follow to improve my own mental health. Then I had (another) grant bounce and realised that, for me, the major contributor to mental health issues in academia is failure. Yes, failure is relative and, yes, there are clearly bigger problems in the world. But in that bitter moment of rejection it’s hard to step back and see that.

Do take it personally

Failure is distressing. The process of grant writing is long and hard; the time it takes to get over grant rejection is long and hard. Even the most thorough, fair and supportive reviewer will not spend as long destroying your hard work as you’ve spent creating it. Failure is stressful. Sadly we are judged on our inputs and outputs, if we are not bringing in money or putting out papers, we feel exposed. And failure is personal. Not only because it is your ideas that are being rejected but also because grants are judged in part on your CV – it is you who is being rejected.
All of which is to say failure sucks. If you are anywhere in an academic environment, you don’t need me to tell you that. But based on the success of the CV of failures, it can help to know that other people are having a bad time too. So if it helps you, I am, currently, having a bad time.

The 24 hour rule

I hope to be having a better time soon. Normally, I allow myself 24 hours to wallow in failure (I’m writing this at hour four). I warn my students that I have a grant decision coming up to give them time to avoid me. I go and find other things to be cross or sad about. I have a drawer of failed applications that I stare at; I contemplate quitting; I swear more and sometimes kick things. Then, at the end of the cycle, I start again with the next application.

Fail less?

So where does that leave me? Essentially, I need to reduce the impact of failure on my mental state. The first approach would be to fail less – either by applying less (a very short term strategy, with a guaranteed result of no job) or by being more successful (essentially impossible – funding rates and paper acceptance rates are both in decline).
The second, more realistic, approach is to find real ways to cope better with failure when it, inevitably, happens. Some of the tools I’ve suggested before – mindset, perseverance, not taking it personally, getting support, taking a step back, getting some perspective (it is only one grant after all) and not acting like a spoilt child – should all help. But sometimes they don’t. Maybe it’s because there are no quick fixes.

Ready player one

However, I have had a moment of clarity. I am (in the gap between work, childcare, running, gardening and husbanding) a gamer. Not a lock-yourself-in-a-darkened-room-for-a-week-to-be-the-first-to-finish-gamer; nor an online gamer, because my reflexes are too slow and I don’t like losing. But a reasonable amount of my spare time is spent killing dragons, fighting aliens and losing to my son at FIFA.
Currently, the game I’m playing most is Dark Souls 2. It’s designed to be hard; and it is really, really, really hard. I repeatedly fail and have to start again; and again, and again, and again. Despite this much failure, I don’t throw my controller down in disgust and quit (that often), in fact, I pay money for the opportunity to fail. So what’s the difference between gaming and grants?
The major difference is that gaming is more enjoyable. Setting aside the personal nature of rejection, failed grants hurt because they feel like time wasted. Admittedly the stakes are lower – I am not going to lose my job if I don’t save the Kingdom of Drangleic from King Vendrick (a gaming reference so nerdy, I am embarrassed even typing it).
Next time, I’m going to try something new: I’m going to try to enjoy the grant writing process. Instead of seeing it as time lost, I will use it as a springboard to do thought experiments, create new ideas, read the literature more widely and improve my writing. Then, when it is rejected, it won’t hurt so much. Probably.

Author’s note
Having written what I believed to be an uplifting end to this, my games console broke, leaving me unable to ever finish the game, which feels like a metaphor for something.

This article first appeared on the NatureJobs Blog: